Immunotherapy does not work for a majority of cancer patients. Preventing or reversing metabolic exhaustion in cancer-killing T-cells could boost its effectiveness.
Anthelmintic drug already approved to treat infections of pinworm parasite was shown to effectively impair both mesothelioma cell growth and migration.
By studying mice in late adolescence, Johns Hopkins University researchers have discovered that the rapid bone growth associated with puberty is slowed not only by fewer cartilage cell divisions but also by the “aging” of bone cell precursor cells. After investigating the signaling molecules that promote this transition, the scientists conclude that some weak and brittle bone conditions in both children and adults may be due to the cells’ premature “retirement” caused by glucocorticoid treatments given during puberty to treat chronic inflammation resulting from rheumatoid disorders and other diseases.
A study published in the March 5 online edition of the Proceedings of the National Academy of Sciences (PNAS) describes how the supercomputers at the San Diego Supercomputer Center at UC San Diego were used to simulate the merger of a G-protein “mimetic nanobody” to a G-protein-coupled receptor (GPCR), the largest and most diverse group of membrane receptors in animals, plants, fungi, and protozoa.
Researchers profiled the epigenomic landscape of Alzheimer’s brains, specifically in one of the regions affected early in AD, the lateral temporal lobe. They compared these to both younger and elderly cognitively normal control subjects. The team described the genome-wide enrichment of a chemical modification of histone proteins that regulates the compaction of chromosomes in the nucleus. Changes along the genome in disease versus normal aging brains may signify places for future drug development.
A genetics research team at Johns Hopkins Medicine has solved a dilemma facing researchers who use genomewide association studies (GWAS) by developing a new approach that strategically “filters” which genes are worth further study. The researchers hope this strategy will accelerate the study of diseases such as Parkinson’s, Alzheimer’s, schizophrenia and even addiction by helping researchers avoid “dead-end paths.” They are optimistic that this strategy will gain widespread use and will save researchers time and money.
RNA makes salt-loving microbes known as “extremophiles” highly resistant to the phenomenon oxidative stress – the uncontrollable production of unstable forms of oxygen called “free radicals,” which can negatively affect DNA, proteins, and lipids in cells.
"The same mechanisms that viruses use to cause cancer may be key in combating tumors with immune-based therapies or in keeping cancer from developing in the first place," says Sharon Kuss-Duerkop, PhD.
Scientists on the Florida campus of The Scripps Research Institute (TSRI) have discovered a new target for treating major depressive disorder, a disease that affects more than 16 million American adults.
Johns Hopkins researchers have invented a new class of cancer immunotherapy drugs that are more effective at harnessing the power of the immune system to fight cancer. This new approach, which was reported in Nature Communications, results in a significant decrease of tumor growth, even against cancers that do not respond to existing immunotherapy.
Researchers have studied the use of bacteria to break down organic contaminants in groundwater; however, this bioremediation process has been met with limited success under some conditions.
Researchers have identified a lung stem cell that repairs the organ’s gas exchange compartment. They isolated and characterized these progenitor cells from mouse and human lungs and demonstrated they are essential to repairing lung tissue damaged by severe influenza and other respiratory ailments.
Newly identified stem cells in the lung that multiply rapidly after a pulmonary injury may offer an opportunity for innovative future treatments that harness the body’s ability to regenerate. Scientists describe cells that could become a new tool to treat lung diseases across the lifespan, from premature infants to the elderly.
Researchers at the George Washington University and the University of Georgia are partners in a project that will soon be able to provide a way for questions asked by those studying glycoscience to be answered by big data.
Engineers from the University of Maryland created a non-flammable battery from ceramic materials by using a 'melty' layer that, when cool, unites a solid-state battery.
A new Medicare records study by Johns Hopkins researchers has added to mounting evidence that a common surgery designed to remove damaged, worn ends of the thin rubbery cartilage in the knee joint brings little or no benefit to people over the age of 65.
A study in the Journal of Neuroscience reveals that activation of a pregnant mother’s immune system can affect her baby’s brain development. Researchers at CHLA, found that short- and long-term brain functioning can be influenced by immune system activity during the third trimester of gestation.
New teaching standards like the Next Generation Science Standards call for weaving science, technology, engineering and math (STEM) into classrooms better. What makes this integration effective?
About 3 out of 4 Americans agree that smoking cigarettes causes health problems, but public perception of the risks posed by smoking may be declining, according to a Duke Health study published in the journal Drug and Alcohol Dependence.
SBP researchers have developed the first ever high-throughput, genome-scale imaging-based approach to investigate protein stability. The method has been used to identify several previously unknown human proteins that HIV degrades to enhance its infection process.
A new study from Indiana University suggests that a compound previously tested to treat osteoarthritis pain appears to block neuropathic pain and decrease signs of opioid dependence.
Blood plasma samples from a mouse that received the Angptl3 CRISPR treatment (right) and a mouse that was untreated (left). The cloudiness of the sample on the left is from the high content of cholesterol and triglycerides.
States with robust tobacco control policies and regulations, such as smoke free air laws and taxes on cigarettes, not only have fewer cigarette users but also fewer e-cigarette users, according to research from NYU School of Medicine and the NYU College of Global Public Health.
A new computational resource called Recon3D provides a 3D view of genes, proteins and metabolites involved in human metabolism. Researchers used the tool to map disease-related mutations on proteins and also probed how genes and proteins change in response to certain drugs. The work provides a better understanding of disease-causing mutations and could enable researchers to discover new uses for existing drug treatments.
Critically ill patients who experience long periods of hypoxic, septic or sedative-associated delirium, or a combination of the three, during an intensive care unit (ICU) stay are more likely to have long-term cognitive impairment one year after discharge from the hospital, according to a new study.
Yarn weaved from carbon nanotubes monitors brain control of organ functions in rats, paves way for disease diagnosis and treatment at single nerve level.
Eating a diet that emphasizes vegetables, fruit and whole grains it may lead to a reduced risk of depression, according to a study by researchers at Rush University Medical Center. Study author Dr. Laurel Cherian will present a preliminary study abstract with these conclusions during the American Academy of Neurology’s 70th Annual Meeting in Los Angeles from April 21 to 27, 2018.
Northwestern University researchers have developed a new “smell virtual landscape” that enables the study of how smells engage the brain’s navigation system. The work demonstrates, for the first time, that the mammalian brain can form a map of its surroundings based solely on smells. The olfactory-based virtual reality system could lead to a fuller understanding of odor-guided navigation and explain why mammals have an aversion to unpleasant odors, an attraction to pheromones and an innate preference to one odor over another.
The finding “opens up a whole new research area to look at neuroinflammation in the context of Alzheimer’s and Parkinson’s,” the lead researcher says. “But the clinical impact will be in many, many different areas.”
Research led by Johns Hopkins physicians and scientists shows that a test for measuring the length of DNA endcaps, called telomeres, which has a variability rate of 5 percent, can alter treatment decisions for patients with certain types of bone marrow failure.
Michelle Ozbun, PhD, is using two grants totaling $2.7 million to learn how human papillomaviruses (HPV) sneak into cells to reproduce. She and her team are also developing new ways in which to measure infections.
Researchers at New York University College of Dentistry, in collaboration with Rheonix, Inc., are developing a novel test for Zika virus that uses saliva to identify diagnostic markers of the virus in a fraction of the time of current commercial tests.
Researchers studying a rare genetic disorder that causes severe, progressive neurological problems in childhood have discovered insights into biological mechanisms that drive the disease, along with early clues that an amino acid supplement might offer a targeted therapy.
To treat cardiovascular disease, surgery can remove blockages in large vessels in the heart or legs but is not possible in small vessels. To address this problem, researchers designed 3D-printed patches seeded with vessel-inducing endothelial cells. In a mouse model of hindlimb ischemia, the researchers identified specific patch patterns that induced growth of organized, tissue-saving blood vessels, demonstrating the potential for the novel technology to address this significant public health problem.
During the West African Ebola outbreak that began in 2013, an experimental biopharmaceutical drug called ZMappTM was a glimmer of hope in the midst of a health crisis. Now, scientists at Texas Biomedical Research Institute in San Antonio have been awarded a $2 million dollar contract by the makers of ZMapp, Mapp Biopharmaceutical, Inc., to further test this promising new therapeutic.
Tim Goetz drives about 200,000 miles each year. Remarkably, Goetz is legally blind. Research funded by the National Eye Institute (NEI) is helping Goetz and others like him get or stay behind the wheel while keeping roads safe for everyone.
A team from The Scripps Research Institute (TSRI) has revealed that by crossing two species of flies, they can use what they learn from the proteome of the hybrid offspring to find new clues about how proteins interact with each other
An international team of researchers led by a Case Western Reserve University School of Medicine scientist has uncovered a novel mechanism in which a protein—neuregulin 3—controls how key neurotransmitters are released in the brain during schizophrenia. The protein is elevated in people with schizophrenia and other severe mental illnesses, but the study is the first to investigate how it causes such severe mental illness.
Paul Marvar, PhD, at GW School of Medicine and Health Sciences, received a large grant from the NIH to study a possible link between post-traumatic stress disorder and cardiovascular disease.
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration process called senescence. Now, researchers at the Johns Hopkins Kimmel Cancer Center demonstrated that instead, tumor-associated epigenetic states evolve erratically during early stages of tumor development, eventually selecting for a subset of genes that undergo the most changes during normal aging and in early tumor development.
In what is believed to be the largest pancreatic cancer genome-wide association study to date, researchers at the Johns Hopkins Kimmel Cancer Center and the National Cancer Institute, and collaborators from over 80 other institutions worldwide discovered changes to five new regions in the human genome that may increase the risk of pancreatic cancer.
Treating food allergies might be a simple matter of teaching the immune system a new trick, researchers at Duke Health have found. In a study using mice bred to have peanut allergies, the Duke researchers were able to reprogram the animals' immune systems using a nanoparticle delivery of molecules to the lymph nodes that switched off the life-threatening reactions to peanut exposures.
Lingering inflammation after heart attack can lead heart failure. It can also claim another victim — the kidneys. New research shows that a bioactive compound called resolvin D-1, injected as a therapeutic dose, is able to limit this collateral damage in the kidneys, as tested in an animal model.
Researchers describe the role of a transcription factor called TCF-1 in targeting the condensed chromatin and regulating the availability of genome sequences in T-cell development. The new connection between TCF-1 and chromatin will aid in developing new therapies using epigenetic drugs to alter T-cell fate in cancer, autoimmune disorders, and infectious diseases.